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Background: GPSM3 is known to bind inactive Gi and act as a GDP dissociation inhibitor, preventing G association.
Results: GPSM3 also interacts with G, independent of Gi binding and excluding a G interaction.
Conclusion: GPSM3 stabilizes G until formation of the G dimer.
Significance: GPSM3 may establish a novel checkpoint in the regulation of heterotrimeric protein subunit dynamics.
Regulation of the assembly and function of G-protein het-
erotrimers (GGDP/G) is a complex process involving the
participation of many accessory proteins. One of these regu-
lators, GPSM3, is a member of a family of proteins containing
one or more copies of a small regulatory motif known as the
GoLoco (or GPR) motif. Although GPSM3 is known to bind
GiGDP subunits via its GoLoco motifs, here we report that
GPSM3 also interacts with the G subunits G1 to G4,
independent of G or GGDP subunit interactions. Bimo-
lecular fluorescence complementation studies suggest that
the G-GPSM3 complex is formed at, and transits through,
the Golgi apparatus and also exists as a soluble complex in the
cytoplasm. GPSM3 and G co-localize endogenously in
THP-1 cells at the plasma membrane and in a juxtanuclear
compartment. We provide evidence that GPSM3 increases
G stability until formation of the G dimer, including
association of the G-GPSM3 complex with phosducin-like
protein PhLP and T-complex protein 1 subunit eta (CCT7),
two known chaperones of neosynthesized G subunits. The
G interaction site within GPSM3 was mapped to a leucine-
rich region proximal to the N-terminal side of its first GoLoco
motif. Both G and GiGDP binding events are required for
GPSM3 activity in inhibiting phospholipase-C activation.
GPSM3 is also shown in THP-1 cells to be important for Akt
activation, a known G-dependent pathway. Discovery of a
G/GPSM3 interaction, independent of GGDP and G
involvement, adds to the combinatorial complexity of the role
of GPSM3 in heterotrimeric G-protein regulation.
G-protein-coupled receptors (GPCRs)2 are a large superfam-
ily of seven transmembrane domain cell-surface receptors
(1–3); the intracellular signals transduced by these heptahelical
proteins are themselves tightly controlled by a guanine nucle-
otide-binding complex of G-protein G, G, and G subunits,
as well as a growing array of regulatory and accessory proteins
(2–6). In the standardmodel of GPCR signaling, ligand binding
to the receptor evokes a conformational change that allows it to
convert G from the inactive GDP-bound form to the active
GTP-bound form (7, 8). GTP-bound G dissociates from the
G dimer to further modulate many intracellular effectors
such as cAMP-generating adenylyl cyclases and phosphatidyli-
nositol 4,5-bisphosphate-hydrolyzing PLC isoforms (9). Sig-
nal termination occurs via the intrinsic GTP hydrolysis activity
of G that restores its GDP-bound state and allows re-associa-
tion with the G dimer; a family of “regulators of G-protein
signaling” (RGS proteins) can dramatically speed this termina-
tion by acting as GTPase-accelerating proteins for various G
subtypes (4, 6, 10).
In the last few years, multiple discoveries have led to the
notion of a more complex regulatory cycle for heterotrimeric
G-protein subunits in the cellular context than the standard
model mentioned above (5, 6). One of these complexities arose
with discovery of the association between inactive GDP-bound
Gi/o subunits and GoLoco motif proteins (5, 6, 11), an associ-
ation that slows the rate of spontaneousGDP release byG (12,
13) and excludes formation of the classical GGDP/G het-
erotrimer (14, 15). Among theGoLoco proteins originally iden-
tified (16–18), one of the smallest at 160 amino acids is GPSM3
(“G-protein signaling modulator type-3”; also known as AGS4
or G18). We and others independently cloned GPSM3 and
characterized its guanine nucleotide dissociation inhibitor
activity on Gi subunits (19, 20). This biochemical activity is
attributed to the first and third GoLoco motifs (GL1 and GL3)
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of the GPSM3 sequence; we have shown that the second
GoLocomotif is inactive because of degeneracywithin a critical
(E/D)QR triad normally highly conserved within GoLoco
motifs (11, 19).
Beyond in vitro guanine nucleotide dissociation inhibitor
activity and a recent report that GPSM3-Gi1 complex forma-
tion can be affected by G-protein-coupled receptor activation
(21), very little has been reported about the functional relevance
of GPSM3 to cellular signal transduction. Here, we report stud-
ies stemming from a yeast two-hybrid screen that identified G
subunits as GPSM3 interactors. Expanding its known reper-
toire of interactors and functions, GPSM3was found to interact
with freeG subunits (in amanner not dependent on the estab-
lished GoLoco motif/Gi interaction) and modulate cellular
signal transduction via the G effector PLC.
EXPERIMENTAL PROCEDURES
Commercial Antibodies, Constructs, and Other Reagents—
Horseradish peroxidase (HRP)-conjugated anti-hemagglutinin
(HA) monoclonal antibody (clone 3F10) was obtained from
Roche Diagnostics. Anti--actin, anti-FLAGM2 antibody, and
agarose-conjugated anti-FLAG M2 antibody were purchased
from Sigma. HRP-conjugated goat anti-mouse and goat anti-
rabbit antibodies were fromGEHealthcare. Anti-phospho-Akt
(Ser-473) and anti-Akt were from Cell Signaling Technology
(Danvers, MA). The expression plasmid for HA-tagged LPA1R
was purchased fromTheMissouri S&T cDNAResourceCenter
(Rolla, MO). All other cDNAs used in this study were cloned in
the pcDNA3.1 backbone vector (Invitrogen) with HA, Myc, or
FLAG epitope tag sequences included in the forward PCR
primer to produce N-terminally tagged open reading frames.
All mutagenesis was performed using the QuikChange site-di-
rected mutagenesis kit following the manufacturer’s recom-
mendations (Agilent Technologies, Santa Clara, CA). The two
GPSM3-specific shRNAs used in this study were developed by
The RNAi Consortium and acquired from University of North
Carolina Lenti-shRNA Core Facility through Open Biosystems
(Huntsville, AL). The pLKO.1 self-inactivating lentiviral vector
drives shRNA expression from a human U6 promoter and car-
ries the puromycin-resistance gene under control of a phospho-
glycerate kinase promoter. Lentiviruses were produced by tran-
sient transfection of pLKO.1 vector plasmids in human
HEK293T cells along with packaging plasmid (pCMV8.9) and
envelope plasmid (VSV-G pHCMV-G) provided by The RNAi
Consortium. Stable THP-1 cell lines expressing GPSM3-spe-
cific shRNAwere produced by lentiviral infection following the
protocol of TheRNAiConsortium. Briefly, exponentially grow-
ing THP-1 cell cultures at low passage were infected with a 1:10
dilution of lentivirus in RPMI 1640 medium (Invitrogen) sup-
plemented with 10% fetal bovine serum (Cellgro, Manassas,
VA) and containing 8 g/ml of Polybrene (Sigma). 48 h follow-
ing lentiviral infection, puromycin (Sigma) was added at a final
concentration of 10 g/ml, and cells were selected for 8 days.
Anti-GPSM3 Antibody Production—Full-length N-termi-
nally His-tagged human GPSM3 protein was produced recom-
binantly in bacteria from a pET vector-based prokaryotic
expression construct using previously described cloning,
expression, and purification techniques (22). Briefly,
BL21(DE3) Escherichia coli expressing His6-hGPSM3 was
grown to an A600 nm of 0.8 at 37 °C before induction with 0.5
mM isopropyl -D-thiogalactopyranoside. After culturing for
14–16 h at 20 °C, cells were pelleted by centrifugation and fro-
zen at 80 °C. Bacterial pellets were then purified using His-
Trap FF columnchromatography according to themanufactur-
er’s instructions (GE Healthcare) and buffer exchanged into
PBS by dialysis. Mouse immunization and hybridoma develop-
ment to produce the mouse monoclonal anti-GPSM3 antibody
35.5.1 were performed under the auspices of the University of
NorthCarolina ImmunologyCore (director, Dr. Bradley Bone).
Cell Culture and Transfection—Human embryonic kidney
293 (HEK293), African green monkey kidney fibroblast (COS-
7), and THP-1 cell lines were each obtained from the American
Type Culture Collection (ATCC) andmaintained in DMEM or
RPMI 1640 medium (THP-1) (Invitrogen) supplemented with
10% fetal bovine serum (Cellgro, Manassas, VA) at 37 °C in a
humidified atmosphere containing 5% CO2. Transient trans-
fections of cell monolayers grown to 75–90% confluence were
performed using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions.
Immunoprecipitation and Immunoblotting—Cells were
lysed with ice-cold lysis buffer (20 mM HEPES, pH 7.5, 1 mM
EDTA, 150mMNaCl, 1%Nonidet P-40, andComplete protease
inhibitor mixture tablets (Roche Applied Science) at 4 °C on a
rocker platform for 30 min. Lysates were clarified by centrifu-
gation at 16,000  g for 15 min at 4 °C and quantified by the
bicinchoninic acid (BCA) protein content assay (Pierce). For
immunoprecipitation, lysates were incubated with specific
antibody for 2 h at 4 °C followed by overnight incubation with
protein-A/G-agarose (Santa Cruz Biotechnology, Santa Cruz,
CA) or directly incubated with agarose-conjugated anti-
FLAG M2 antibody overnight. Pelleted antibody-bead com-
plexes were then washed three times with lysis buffer and
proteins eluted in Laemmli buffer. Eluted proteins or lysate
samples were resolved on 4–12% precast SDS-polyacryl-
amide gels (Novex/Invitrogen), transferred to nitrocellulose,
immunoblotted using primary and HRP-conjugated second-
ary antibodies, and visualized by chemiluminescence (ECL,
GE Healthcare).
Mass Spectrometry Analysis—Immunoprecipitation of
FLAG-GPSM3 after cellular co-transfection of FLAG-GPSM3
and HA-G2 DNA constructs was performed as described
above from 6 wells of a 6-well plate with agarose-conjugated
anti-FLAGM2 antibody overnight and resolved on 4–12% pre-
cast SDS-polyacrylamide gels. Gel was fixed and stained with
SYPRO Ruby gel stain following the manufacturer’s protocol
(Invitrogen). The band of interest was excised and sent to MS
Bioworks LLC (Ann Arbor, MI) for processing and analysis by
nano-LC/MS/MS.
Inositol Phosphate Accumulation Assay—COS-7 and
HEK293 cells were seeded in 12-well plates at a density of 1.5
105 and 6  105 cells per well, respectively. The next day, cells
were transfectedwithDNAplasmids using Lipofectamine 2000
according to the manufacturer’s instructions. The following
day, cells were metabolically labeled for 18 h with myo-[3H]-
inositol at 8 Ci/ml in inositol-free DMEM (MP Biomedicals,
Solon,OH) containing 0.5%BSAand 20mMHEPES, pH7.5.On
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the day of the experiment, cells were washed once with phos-
phate-buffered saline (PBS) and then incubated in prewarmed
DMEM (without inositol) containing 0.5% BSA, 20mMHEPES,
pH 7.5, and 35 mM LiCl for 10 min. Thereafter, cells were stim-
ulated with 10M lysophosphatidic acid (or vehicle control) for
60 min. Following stimulation, the medium was removed, and
the reactions were terminated by addition of 150 l of 50 mM
formic acid and incubation for 1 h at room temperature. Then
50 l of formic acid supernatant was mixed with 75 l of 2.67
mg/ml SPA beads diluted in ice-cold water (RNA-binding YSi
beads, GEHealthcare) in a 96-well/plate and agitated at 4 °C for
30min. The radioactivity was countedwith aWallacMicroBeta
luminescence counter (PerkinElmer Life Sciences).
Bimolecular Fluorescence Complementation (BiFC)—Fusion
constructs were made similar to those previously described for
G tracking (23), namely a fusion of the N-terminal fragment
(amino acids 1–158) of yellow fluorescent protein (YN) to theN
terminus of full-length GPSM3 (“YN-GPSM3”) and the C-ter-
minal fragment (amino acids 159–238) of YFP (YC) to the C
terminus of G2 (“G2-YC”). HEK293 cells were transfected
with an equal amount of plasmids encoding the fusion proteins
YN-GPSM3 and G2-YC, and cells were incubated at 37 °C for
24 h. Total DNA quantity was normalized using empty
pcDNA3.1 vector DNA. Tomeasure fluorescence from formed
complexes, transfected cells werewashed, harvested, and resus-
pended in PBS. BiFC signal was acquired using a Mithras
LB-940 plate reader (Berthold Technologies, Oak Ridge, TN)
using an excitation/emission filter set of 485 and 510 nm. The
level of expression of each fusion protein was quantified by
Western blotting using a polyclonal antibody directed against
the GFP.
Bioluminescence Resonance Energy Transfer (BRET)—
HEK293 cells were seeded in 12-well plates (3.5  105 cells/
well) and transfected with a fixed amount of G1-Rluc vector
DNA (50 ng) and with increasing amounts of GFP10-GPSM3
vector DNA (0–1500 ng) and corresponding (decreasing)
amounts of pcDNA3 empty vector (1500 to 0 ng) to obtain a
saturation curve. The competition BRET assay was performed
by transfecting cells with 50 ng of G2-RLuc vector, 750 ng of
GFP10-G1 vector with 750 ng of FLAG-GPSM3 or pcDNA3
vector, or by transfecting 50 ng of G1-RLuc vector and 750 ng
GFP10-GPSM3 vector with 750 ng ofHA-G2 or pcDNA3 vec-
tor. 24 h post-transfection, cells were washed once, harvested,
and resuspended in BRET buffer (phosphate-buffered saline
with 1 mM CaCl2, 0.5 mMMgCl2, 0.1% glucose) and distributed
in white 96-wells microplates. BRET was initiated by adding
coelenterazine 400a at a final concentration of 5 M. Measure-
ments of emitted light were collected on a Mithras LB-940
plate-reader (Berthold Technologies) using a BRET2 filter set.
Immunofluorescence Confocal Microscopy—HEK293 cells
were seeded in a 12-well plate and transfected with 0.4 g of
each DNA, YN-GPSM3 and G2-YC. Then 100 l of Cell-
LightTM Golgi-RFP Bacman 2.0 (Invitrogen) was added as a
Golgi marker. The following day, cells were transferred to a
poly-D-lysine-coated coverslip in a 6-well plate and grownover-
night. For Golgi disruption, a final concentration of 20 g/ml
brefeldin A (BFA) was added to the cells 15 min prior to fixa-
tion. For endogenous protein labeling, 1.0  106 THP-1 cells
were grown for 72 h on poly-D-lysine-coated coverslips in
6-well plates in the presence or absence of 50 ng/ml phorbol
12-myristate 13-acetate (PMA). Cells were then fixed with 4%
paraformaldehyde plus PBS for 10 min at room temperature.
Cells were then washed with PBS and permeabilized with 0.1%
Triton X-100 plus PBS for 30 min at room temperature. Non-
specific binding was blocked with 0.1% Triton X-100 plus PBS
containing 5% nonfat drymilk for 30min at room temperature.
Cells were then incubated with GPSM3-specific mouse
monoclonal antibody 35.5.1 (1:100 dilution) and with a pan-
G-specific rabbit polyclonal antibody from Santa Cruz Bio-
technology (M-14; 1:100 dilution) for 1 h at room temperature
in PBS supplemented with 5% nonfat dry milk. Then cells were
washed three times with PBS containing 0.1% Triton X-100,
followed by incubation with a goat fluorescein isothiocyanate-
conjugated anti-mouse secondary antibody and a goat Texas
Red-conjugated anti-rabbit antibody (Molecular Probes, Carls-
bad, CA) at dilutions of 1:200 for 1 h at room temperature. Cells
were then washed three times with permeabilization buffer.
Finally, coverslips were mounted using Vectashield mounting
medium (Vector Laboratories, Burlingame, CA) and examined
by confocal microscopy (Olympus Fluoview FV1000) using a
60 oil immersion objective. Co-localization was assessed by
the examination of merged images that showed co-localized
regions. In addition to the merged image, an extracted merged
pixels picture was generated using Image-Pro software (Media
Cybernetics, Bethesda). Images were collected and processed
with Image-Pro Plus 6.0 and Adobe Photoshop CS4 software.
RESULTS AND DISCUSSION
Identification of G Subunits as Novel GPSM3 Interacting
Partners—In a pilot experiment to test the effects of GPSM3 on
cellular GPCR signaling, we found that ectopic GPSM3 expres-
sion in HEK293 cells inhibited signaling of the agonist-acti-
vated lysophosphatidic acid receptor LPA1R to endogenous
PLC activation and the generation of inositol phosphate (Fig.
1A, left panel). Surprisingly, ectopic GPSM3 expression was
also found to inhibit PLC2 activation by G dimer stimula-
tion in COS-7 cells (Fig. 1A, right panel). Currently, the only
established binding partners for GPSM3 are G subunits of the
Gi/o family (19, 20, 24).
To help identify additional interacting partner(s) of GPSM3
that might explain its effect on G-dependent effector activa-
tion, we performed a yeast two-hybrid screen. Using full-length
GPSM3 as bait, we screened 106 human leukocyte cDNAclones
from a commercial library. Our screen identified two different
clones encoding Gi2, as expected given the two functional
GiGDP-interacting GoLocomotifs (GL1 and GL3) present in
GPSM3 (amino acids 63–81 and 133–152, respectively (19)).
Two different clones of the G1 subunit were also identified in
the screen. Fig. 1B shows the specific interaction between
GPSM3 and G1 in yeast with purified bait and prey clones
transfected and yeast grown under auxotrophic selection.
Although multiple other GoLoco motif-containing proteins
have demonstrated interactionswithGi/o familyG subunits in
yeast two-hybrid screens (e.g. LGN, Pcp2, and Rap1GAP (25–
27)), none of these reports identified G subunits as binding
partners.
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FIGURE 2. GPSM3 interacts with all conventional G-protein  subunits and all Gi subunits. A, COS-7 cells were transiently co-transfected with plasmids
expressing FLAG-tagged GPSM3, HA-tagged G2, and/or HA-tagged G subunits as indicated. Immunoprecipitation (IP) of GPSM3 was performed using
agarose-conjugated anti-FLAG M2 antibody, and co-immunoprecipitating proteins were detected by immunoblotting (IB) with anti-HA epitope tag antibody.
All four G subunits (G1 to G4) were observed to co-immunoprecipitate with FLAG-GPSM3, but without concomitant co-immunoprecipitation of the
HA-tagged G2 subunit. B and C, to eliminate a trivial explanation that the absence of detectable HA-tagged G2 was perhaps a technical issue with
immunoblotting for such a small polypeptide, the reciprocal co-immunoprecipitation was also performed (i.e. immunoprecipitation of tagged G and G
subunits). COS-7 cells were co-transfected with Myc-tagged G1 and HA-tagged G2 in the presence or absence of FLAG-tagged GPSM3; resultant cell lysates
were immunoprecipitated using a polyclonal anti-Myc (B) or monoclonal anti-HA (C) antibodies and interacting proteins detected by immunoblotting with
anti-Myc, anti-HA-, and anti-FLAG-HRP conjugates. RIPA-buffer solubilized fractions from each co-transfection condition were loaded as controls and marked
as lysate. All experiments were repeated at least three times with identical results. D, HEK293 cells were transiently co-transfected with FLAG-tagged GPSM3
and HA-tagged G2, and immunoprecipitation of FLAG-GPSM3 was performed using agarose-conjugated anti-FLAG M2 antibody. Immunoprecipitates were
resolved on a 4 –12% NUPAGE SDS-PAGE, and component proteins were visualized by SYPRO Ruby staining, and an apparent band at 40 kDa was excised for
LC/MS/MS peptide sequence identification. The four hits showing the highest spectral counts are shown. Co-expressed G2 shows the highest counts, and all
three endogenous Gi subunits were also detected.
FIGURE 1. Inhibition of G-mediated signaling by GPSM3 and identification of G1 as a GPSM3-interacting protein in a yeast interaction trap screen.
A, inositol phosphate accumulation was measured in HEK293 cells upon agonist-induced activation of the lysophosphatidic acid receptor LPA1R co-trans-
fected with the LPA1R expression vector and the indicated cDNAs (left panel) or in COS-7 cells upon triple co-transfection with expression vectors for PLC2,
G1, and G2, along with indicated cDNAs. Response was normalized to inositol phosphate accumulation measured in cells transfected with control vector
(empty pcDNA3.1). ***, p  0.001 by one-way ANOVA. B, Saccharomyces cerevisiae (budding yeast) was co-transformed with indicated bait plasmids (either
expressing the Gal4p DNA binding domain alone (pAS2-1) or as a fusion with full-length GPSM3 (pAS2-1/GPSM3)) and prey plasmids (either expressing the
Gal4p activation domain alone (pGAD424) or as a fusion with the entire human G1 open-reading frame (pACT2/G1)). Transformed yeast were plated onto
synthetic defined agar (Yc) lacking leucine (Leu, to select for the prey plasmid) and tryptophan (Trp, to select for the bait plasmid); growth on Yc Leu Trp
medium demonstrates incorporation of both bait and prey plasmids (top panel). Growth on Yc Leu Trp medium also deficient in adenine (Ade) and
histidine (His) indicates a positive protein/protein interaction (bottom panel).
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To confirm this novel discovery of an interaction between
GPSM3 and G subunits, we performed co-immunoprecipita-
tion experiments in COS-7 cells. All four conventional G sub-
units were observed to co-immunoprecipitate with GPSM3
(Fig. 2A); given the hematopoietic restricted expression of
GPSM3,3 we excluded analysis of the neuron-specific, G fam-
ily outlier G5 that is known to associate with R7-RGS proteins
rather than conventional G subunits (28). Cell lysates used in
these experiments contained no added nucleotide nor alumi-
num tetrafluoride (i.e. performedwithout forcing any activeG
nucleotide state that could release G protein from intact
heterotrimers).
We were surprised to observe that GPSM3 could co-immu-
noprecipitate with G subunits in the absence of co-immuno-
precipitated G subunits; however, there is precedence for this
type of interaction, even beyond theG5/R7-RGS protein pair-
ings (28), given that phosducin-like proteins (PhLPs) have been
shown to bind monomeric G subunits in their role as chaper-
ones for newly synthesized G proteins prior to their associa-
tion with G subunits (29, 30). Fig. 2 demonstrates reciprocal
co-immunoprecipitation experiments that serve to exclude any
technical issue of detecting the small molecular weight G sub-
unit. Immunoprecipitation of Myc-tagged G1 was seen to co-
immunoprecipitate either GPSM3 or theG2 subunit (Fig. 2B);
co-expression of G with both GPSM3 and G slightly dimin-
ished the detection of both G-GPSM3 and G complexes
(Fig. 2B, last lane), whereas immunoprecipitation ofHA-tagged
G2 co-immunoprecipitates only Gwithout being affected by
the presence of GPSM3 (Fig. 2C). We also tested other HA-
tagged isoforms of G subunits and found that neither G1,
G11, nor G13 was present in immunoprecipitated
G-GPSM3 complexes (supplemental Fig. S1).
Tandemmass spectrometry was also used as an independent
means to detect GPSM3 complex formation with G-protein
subunits. Ectopically expressed FLAG-tagged GPSM3 was
immunoprecipitated from HEK293 total cell lysate; the result-
ant immunocomplex was separated by one-dimensional SDS-
PAGE and visualized by subsequent SYPRO Ruby protein gel
staining. A predominant band at 40 kDa was observed,
excised, and analyzed byMS/MS. Fig. 2D lists the first four hits
observed with the highest spectral counts. The G2 subunit
was the most prominent protein present in the complex, fol-
lowed by all three isoforms of Gi subunits.
Confirmation of the G/GPSM3 Interaction in Cells Using
BiFC and BRET—As an additional independent measure of the
G/GPSM3 interaction, and to locate this interaction in the
cellular context, we used BiFC (31, 32) with split YFP-tagged
GPSM3 and G2 fusion constructs. If an interaction occurs
between fusion partners (in this case, GPSM3 and G2), the
fluorophore of YFP is reconstituted, although the interaction is
irreversible, preventing normal interaction dynamics between
the two proteins (31, 32). This irreversibility can be advanta-
geous in these studieswhen twoproteins are thought to interact
transiently, a property we expect for the G/GPSM3 interac-
tion, given the following: (i) GPSM3 interacts with free G
rather than the G dimer (Fig. 2); (ii) G apparently competes
with GPSM3 for G (Fig. 2B); and (iii) once formed, the G
dimer is considered indissociable (33, 34), reducing the likeli-
hood that GPSM3 induces G dimer dissociation.
Expression of each construct alone (YN-GPSM3 orG2-YC)
gave minimal observable fluorescence (Fig. 3A); expression of
each construct with a control counterpart (i.e. the paired fluo-
rescent protein fragmentwithout the fusion bait) also gave little
fluorescence even at high levels of overexpression (data not
shown). When combined, the pairing of YN-GPSM3 and
G2-YC expression plasmids yielded a strong cellular fluores-
cence signal that was inhibited by co-expression of nontagged
G2 (Fig. 3A), an additional measure of the specificity of the
YN-GPSM3/G2-YC interaction.
Subcellular localization of the complex formed between YN-
GPSM3 and G2-YC was investigated using confocal micros-
copy. Two different expression patterns were reproducibly
observed when multiple cells were analyzed. One pattern is
shown in Fig. 3B, panels a–d, in whichmost of the fluorescence
from the G-GPSM3 complex is located in the cytoplasm with
some co-localization with a Golgi marker (Golgi-RFP; Fig. 3B,
panel d). Co-localization of the two proteins at the Golgi sug-
gests that the initial interaction between GPSM3 and G sub-
units occurs early during G neosynthesis. The second pattern
observed is illustrated in Fig. 3B, panels e–h, in which the
majority of the fluorescence signal forms an intracellular spot in
a juxtanuclear region close to theGolgimarker. To confirm that
this pattern of G-GPSM3 complex localization is exclusive of
the Golgi apparatus, we treated cells with BFA. Treatment with
BFA disrupted the Golgi (Fig. 3B, panels i–l) as expected (35),
but it did not disrupt formation of the G-GPSM3 complex at
its juxtanuclear location (e.g. Fig. 3B, panel i).
Based on our findings with YN-GPSM3 and G2-YC co-ex-
pression (e.g. Fig. 3B), the G-GPSM3 complex seems to be
formed in and traffic through the Golgi apparatus, but it
appears to reside in a distinct structure rather than being
trapped in the Golgi when irreversibly tethered via YFP fluoro-
phore reconstitution. This observation is highly reminiscent of
aggresome formation- juxtanuclear structures that form
around the microtubule organizing center with no or partial
co-localization with the Golgi (36, 37). The formation of
aggresomes by irreversibly tethered G-GPSM3 complexes is
consistent with the idea that BiFC disrupts the normal dynamic
interaction that occurs between two proteins and can lead to
accumulation of this complex in an inclusion body to protect
cells from potentially toxic aggregates (36).
To overcome any bias caused by a loss of normal interaction
dynamics in BiFC, we also used BRET to directly monitor the
interaction between GPSM3 and G in living cells. The speci-
ficity of the interaction was confirmed by a BRET saturation
experiment. Expression of a constant amount of a G1-RLuc
(Renilla luciferase) fusion protein with increasing amounts of
GFP10-GPSM3 fusion protein showed a saturable interaction
(Fig. 3C). Confirming results previously obtained by co-immu-
noprecipitation (Fig. 2B), G2 was seen using BRET to inhibit
the complex formation between GPSM3 and G; expression of
3 Suggestions of a hematopoietic lineage restriction of GPSM3 expression are
derived from unpublished observations of M. Branham-O’Connor and J. B.
Blumer cited in Ref. 21; see also P. M. Giguère, G. Laroche, and D. P. Sid-
erovski, manuscript in preparation.
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untagged G2 greatly diminished the BRET signal detected
between G1-RLuc and GFP10-GPSM3 (Fig. 3D). Conversely,
expression of untagged GPSM3 did not affect the BRET signal
betweenG2-RLuc andGFP10-G1 fusions (Fig. 3E), similar to
the co-immunoprecipitation data of Fig. 2C and supporting the
idea that GPSM3 interacts with G before formation of the
G dimer such that GPSM3 cannot induce dissociation of
the tight G dimer.
G-GPSM3 Complex Associates with PhLP and CCT7 and
Stabilizes the G Moiety—Several studies have shown that G
andG subunits traffic through theGolgi apparatus where they
associate together in a process involving chaperone proteins
such as PhLP, T-complex protein 1 subunit eta (CCT7), and
DRiP78 (38–40). Once properly folded, G dimers then
translocate to the plasma membrane. We found that when co-
expressedwithMyc-G2, FLAG-taggedGPSM3 can co-immu-
noprecipitate with PhLP (Fig. 4A), a protein known to bind
directly to isolated (i.e. non-G-complexed) G subunits (29,
38).Wewere also able to co-immunoprecipitate theCCT7 sub-
unit with FLAG-GPSM3whenHA-G2 was co-expressed (Fig.
4B). CCT7 is a subunit of the cytosolic chaperonin containing
T-complex polypeptide 1 (CCT)/TRiC group II chaperonin
that assists in folding of newly synthesized WD40-containing
proteins such as G subunits (41). Both PhLP and CCT7 were
initially detected as GPSM3-interacting proteins in our yeast
two-hybrid screen. These results support the idea that GPSM3
andG associate early duringGbiosynthesis and prior toG
dimer assembly.
DRiP78 is known to associate with neosynthesized G, serv-
ing as a chaperone-like molecule to stabilize G in a conforma-
tion suitable for proper assemblywithG (40).We thus used an
approach similar to that of DRiP78/G interaction studies to
quantify the effect of GPSM3 on G stabilization, namely mea-
suring the cellular fluorescence of GFP-tagged G in the
absence or presence of cycloheximide (blockingde novoprotein
synthesis). As observed previously (40), co-expression of G2
stabilized GFP10-tagged G1 from degradation (Fig. 4C, bar 1
versus 2). Co-expression of GFP10-G1 with GPSM3 was also
found to stabilize the G subunit, to a higher degree than G2
co-expression (Fig. 4C, bars 1–3). Co-expression with G2
FIGURE 3. Analysis of GPSM3 and G interaction using BiFC and BRET. A and B, HEK293 were transfected with plasmids expressing YN-GPSM3 (amino acids
1–158 of YFP fused to GPSM3) and G2-YC (G2 fused to amino acids 159 –238 of YFP) and the fluorescence reconstituted YFP fluorophore was assayed at 24 h
post-transfection. A, cells were harvested and fluorescence quantified on a plate reader. Total DNA used for transfection was normalized using empty
pcDNA3.1 vector DNA. Data are expressed as relative fluorescence units (RFU) using the means  S.E. of at least three different experiments. B, confocal
microscopy images of HEK293 cells transfected with plasmids expressing the two YFP protein fragment fusions (panels a, e, and i) and Golgi-RFP (panels b, f, and
j). Panels a and e show the two different subcellular localization patterns (cytosolic and juxtanuclear) observed for the YN-GPSM3/G2-YC complex. Panels i, j,
k, and l represent cells treated with BFA prior to fixation. BFA was seen to disperse the Golgi apparatus (panel j) but only partially disperse the YN-GPSM3/
G2-YC complex from its juxtanuclear position. Panels c, g, and k represent the fluorescence signal from the YN-GPSM3/G2-YC complex overlaid with the
Golgi-RFP marker signal, and panels d, h, and l represent the corresponding co-localization as assessed by extracting co-incident pixels from each fluorophore
signal (Mask). The bar represents 10 m in all images. C, interaction between GSPM3 and G was also confirmed by a BRET saturation experiment. A constant
amount of G1-RLuc fusion expression vector was co-transfected into HEK293 cells with increasing amounts of GFP10-GPSM3 fusion expression vector; the
resultant net BRET ratio was plotted as a function of the acceptor/donor ratio. The specificity of the interaction is indicated by the saturable nature of the BRET
signal. D and E, co-expression of G2 is presumed to displace GPSM3 from its G subunit interaction, as suggested by a reduction of the BRET signal between
G1-RLuc and GFP10-GPSM3 fusion (D), although co-expression of untagged GPSM3 was not seen to perturb the BRET signal obtained from the G2-RLuc/
GFP10-G1 fusion pair (E), suggesting that the GPSM3 interaction with G subunits occurs before formation of the G dimer.
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along with GPSM3 was observed to reduce the stabilization
effect of GPSM3 to the level observed with G alone (Fig. 4C,
bars 2–4), supporting the notion that G likely displaces
GPSM3 from G (consistent with the results of Figs. 2 and 3
suggesting mutually exclusive G-GPSM3 and G
complexes).
During these stability/protection experiments, we found the
basal fluorescence of GFP10-G1 (i.e. before blocking protein
synthesis with cycloheximide) was affected dramatically by
GPSM3 co-expression, whereas G expression had no effect on
fluorescence intensity (e.g. Fig. 4D, bars 1 and 2 versus 3). We
used this phenomenon to observe that the influence of G
expression superseded that ofGPSM3, given that graded reduc-
tions in GFP10-G1 fluorescence enhancement were seen
upon greater quantities of G2 cDNA co-transfected with
GPSM3 and GFP10-G1 (Fig. 4D, bars 4–6). Taken together,
these experiments suggest that GPSM3 interacts with and
thereby stabilizes G, and this interaction occurs until G dis-
places GPSM3 to form the mature G dimer. The absence of
an effect by G2 overexpression on the basal fluorescence
intensity of overexpressed GFP10-G1 likely reflects that, once
the G complex is formed, it is subjected to normal turnover
as a native and functional complex.
Detection of anEndogenousG/GPSM3 Interaction inMono-
cytic THP-1 Cell Line—Further establishing the G/GPSM3
interaction, we were able to co-immunoprecipitate endoge-
nous G subunits along with endogenous GPSM3 from THP-1
cell lysate using our anti-GPSM3 monoclonal antibody 35.5.1
(Fig. 5A, inset). As detected by confocal microscopy using a
commercial pan-G antibody, endogenous G subunits were
co-localized with GPSM3 at the plasma membrane in THP-1
cells (Fig. 5A). Juxtanuclear intracellular pools of the two pro-
teins were also detected that correspond to a Golgi proximal
complex (Fig. 5A, Mask panel, arrows), as also observed in the
BiFC overexpression experiments.
Plasma membrane co-localization of endogenous G and
GPSM3 proteins in THP-1 cells is consistent with the recent
report from Oner et al. (21) in which GPSM3 was shown (by
BRET analyses) to be capable of forming a G-protein-depen-
dent complex in proximity to plasma membrane-delimited
GPCRs (i.e. the 2-adrenergic receptor). We confirmed a
plasma membrane-delimited association between GPSM3 and
G subunits using an imaging FRET approach in HEK293 cells.
Venus-tagged GPSM3 was co-expressed with cyan fluorescent
protein-tagged G2 and analyzed by FRET acceptor photo-
bleaching (42). This approach measures donor “de-quenching”
FIGURE 4. G-GPSM3 complex associates with PhLP and CCT7 and stabilizes the G moiety. A and B, to assess the potential interaction between the
G-GPSM3 complex and PhLP and CCT7 proteins, HEK293 cells were transiently co-transfected with plasmids expressing the FLAG-tagged GPSM3, HA-tagged
PhLP, and Myc-tagged G2 subunit (A) or the FLAG-tagged GPSM3, HA-tagged CCT7, and HA-tagged G2 subunit (B) as indicated. Immunoprecipitation (IP)
of GPSM3 was performed using agarose-conjugated anti-FLAG M2 antibody, and co-immunoprecipitating proteins were detected by immunoblotting (IB)
with anti-HA or -Myc epitope tag antibodies. C and D, GFP10-G1 was co-expressed with either empty vector (pcDNA3.1), G2, GPSM3, or GPSM3 and G2
together to verify the effect of these proteins on GFP10-G1 stability. Cells were transfected and 24 h post-transfection were treated with cycloheximide (150
g/ml) (C) or not (D) for 3 h prior to harvesting and measurement of total GFP fluorescence. Data are expressed as % of total fluorescence measured before
cycloheximide treatment (C, % protection) or to GFP10-G1 transfected alone (D, % RFU (relative fluorescence units)). The means  S.E. of at least three different
experiments are plotted; *, p  0.05; **, p  0.01, and ***, p  0.001 by one-way ANOVA.
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after destruction of the acceptor by photobleaching. The sup-
plemental Fig. S2 illustrates that increased FRET efficiency was
observed both at the plasma membrane and in the cytoplasm.
As the monocytic THP-1 cell line can be easily differentiated
to macrophage-like cells via phorbol ester treatment (43–45),
we examined the cellular distribution of GPSM3 and G sub-
units following this process. THP-1 cells were differentiated
with PMA for 72 h and immunostained for endogenousGPSM3
andG expression (Fig. 5B). DifferentiatedTHP-1 cells showed
a clear reduction of GPSM3 immunostaining, with the remain-
ing staining localized in the cytoplasm as punctate structures.
We found a similar redistribution of G subunits, although
overall expression was not affected (Fig. 5B). G relocalization
to cytoplasmic puncta co-localizes with the remaining GPSM3
signal, as observed in theMask panel of Fig. 5B.
G/GPSM3 Interaction Is Not Dependent on the GiGDP/
GoLoco Motif Interaction—A simple explanation for the
G/GPSM3 interaction could potentially be found in the
known association of GPSM3 GoLoco motifs with inactive-
state GiGDP subunits (19, 20), the latter proteins being well
established as high affinity binding partners for G dimers
when in this particular nucleotide state (33). However, bio-
chemical, cellular, and structural analyses of the GiGDP/
GoLoco motif interaction have strongly suggested mutual
exclusion of this interaction versus formation of the GiGDP/
G heterotrimer (14, 15). Yet, more recently, evidence of a
second high affinity G-binding site on Gi1GDP has been
reported (46). To exclude the possibility that the observed
G/GPSM3 interaction is somehow brokered by the GiGDP/
GoLoco motif interaction, we performed additional co-immu-
noprecipitation experiments. We produced a GPSM3 loss-of-
function double point mutant (called “RF”) in which both
arginines that are part of the critical GoLoco triad motif ((E/
D)QR) of the active GoLoco motifs GL1 and GL3 (Arg-81 and
Arg-152) were mutated to phenylalanine. This Arg-to-Phe
point mutation eliminates binding of Gi subunits to GoLoco
motifs (13, 14), including both of the active GoLoco motifs
withinGPSM3 (19). Fig. 6A presents co-immunoprecipitation
results re-affirming that the double GoLoco mutant GPSM3
exhibits greatly reduced binding to Gi1 subunits. This dou-
ble GoLoco mutant was then used to evaluate whether or not
Gi could bridge the interaction between G and GPSM3.
G1 was observed to co-immunoprecipitate with the double
Arg-to-Phe GPSM3mutant as well as with wild-type GPSM3
(Fig. 6B, compare lanes 5 and 8), excluding the possibility
that Gi serves as a linker between GPSM3 and G subunits.
A reduction in the amount of the G-GPSM3 complex was
observed when Gi1 was co-expressed, and this reduction
was less pronounced with the RF mutant (Fig. 6B, compare
lanes 6 and 9). This reduction may result from some form of
steric hindrance or intramolecular regulation of GPSM3 by
the binding of Gi1 to one of its GoLoco motifs, possibilities
that will need to be tested in the future using recombinant
protein interaction studies.
Identification of a G Interaction Site within GPSM3—From
multiple truncation experiments (e.g. supplemental Fig. S3), we
FIGURE 5. Endogenous GPSM3 is co-localized with endogenous G subunits at plasma membrane and juxtanuclear positions in THP-1 cells. Endog-
enous GPSM3 was detected in untreated (A) and PMA-differentiated (B) THP-1 cells by confocal microscopy using indirect immunofluorescence staining with
anti-GPSM3 monoclonal antibody 35.5.1 and FITC-labeled anti-mouse secondary antibody; endogenous G subunits were concomitantly detected with a
rabbit polyclonal pan-G antibody and Texas Red-labeled anti-rabbit secondary antibody. G/GPSM3 co-localization was assessed by extracting the co-inci-
dent pixels from each fluorophore signal (Mask). Inset, whole cell lysate from THP-1 cells was immunoprecipitated (IP) with the anti-GPSM3 mouse monoclonal
antibody 35.5.1 or an IgG2 isotype control (ctrl); endogenous G subunits were subsequently detected using a pan-G subunit antibody. IB, immunoblot. Scale
bar, 10 m.
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were able to discern a minimal G interaction site between
amino acids 50 and 70 of GPSM3. This region begins N-termi-
nal to the first GoLoco motif of GPSM3 (GL1; amino acids
63–81) and overlaps with the first eight residues of the GL1
motif (Fig. 7A). This region contains multiple leucine residues
within a span of a probable -helix secondary structure (19).
Mutation of all leucines between amino acids 58 and 68 either
to alanine or to serine, within the context of full-lengthGPSM3,
eliminated interaction with G1 (e.g. Fig. 7B, “mutant M3”).
The extensive number of point mutations, while implicating
this leucine-rich hydrophobic region in G binding, also dis-
rupted interaction between Gi1 and the GL1 GoLoco motif
(data not shown). As the GL3 region of GPSM3, when tested in
isolation, did not show anyG interaction (data not shown), we
therefore used a sequence alignment of these two active
GoLoco motif regions (GL1 versus GL3 plus adjoining N-ter-
minal residues) to predict new point mutations that would
affect the G interaction without affecting the Gi1/GL1 motif
interaction. The GL1 and GL3 motifs are highly conserved,
including the first leucine-rich -helix (Fig. 7A), so we focused
on the proximal amino acids N-terminal to the GL1 GoLoco
motif. This region upstream of the GL1 motif (57LLSLQTEL64)
was then mutated to either LPLPQTEL or LPLPQTQE
(sequences closer to those found in the GL3 motif region), and
FIGURE 6. G/GPSM3 interaction is not dependent on the GiGDP/GoLoco motif interaction. A, to validate that Gi binding is eliminated by loss-of-
function point mutations to the first and third GoLoco motifs of GPSM3 (R81F and R152F, called RF), COS-7 cells were co-transfected with indicated GPSM3 and
Gi1 cDNAs and subjected to immunoprecipitation (IP) with agarose-conjugated anti-FLAG M2 antibody and immunoblotting (IB) with anti-FLAG or anti-KT3
epitope tag antibodies as indicated. B, to test for the G/GPSM3 interaction in the absence of functional GoLoco motifs, wild-type or RF mutant GPSM3 cDNA
was co-transfected with indicated Gi1 and/or G1 cDNAs into COS-7 cells, and resultant whole cell lysates were subjected to immunoprecipitation and
immunoblotting as described for A. Immunoglobulin heavy and light chains are denoted IgH and IgL, respectively.
FIGURE 7. A leucine-rich motif in GPSM3 is critical for G interaction. A, polypeptide sequence of human GPSM3 illustrating locations of the consensus GL1
and GL3 GoLoco motifs (as defined in Ref. 11), the inactive GL2 GoLoco motif lacking the acidic amino acid of the (E/D)QR triad (dashed underline in GL2; solid
underline in GL1 and GL3) (19), and the arginine 81 and 152 residues (asterisks) mutated to phenylalanine to eliminate Gi binding to the GL1 and GL3 motifs,
respectively. The tripeptide sequence 58LSL, N-terminal to the GL1 motif, is displayed in a black box, as is the cognate sequence from the same position
N-terminal to the GL3 motif. B and C, COS-7 cells were co-transfected with the indicated cDNA constructs and resultant whole cell lysates subjected to
immunoprecipitation (IP) with agarose-conjugated anti-FLAG M2 antibody and immunoblotting (IB) using indicated antibodies. GPSM3 mutant M1, in which
the tripeptide sequence 58LSL was replaced with proline-leucine-proline, was observed to nearly eliminate the co-immunoprecipitation of G1 (B) but preserve
binding to Gi1 (C).
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the resultant full-length GPSM3 constructs were tested for
their ability to bindG andGi subunits. Theminimal 58LSL60-
to-PLP mutation was found to reduce dramatically the
interaction with G (Fig. 7B,mutant M1) while preserving the
binding of GPSM3 to Gi1 (Fig. 7C).
Role of G/GPSM3 Interaction in Modulating Cellular
Signaling—The 58LSL60-to-PLP (called “LSL”) mutant of
GPSM3 presented the opportunity to investigate the role of the
G interaction without affecting Gi binding. We returned to
examining the effect of GPSM3 on the PLC signaling pathway
as it is a well established effector of G dimers (47). Two
approaches were used, one via activation of the lysophospha-
tidic acid receptor LPA1R in cells expressing endogenous PLC
and the other by ectopic PLC2 overexpression. In both cases,
overexpression ofwild-typeGPSM3was found to inhibit recep-
tor-stimulated inositol phosphate production by 50%,
whereas the loss-of-function LSLmutant did not elicit any inhi-
bition (Fig. 8, A and B). As the primary known function of
GPSM3 is to interactwith the inactiveGDP-bound formofGi,
we also examined the effect of the double RFmutant, for which
Gi binding is strongly reduced. The RF mutant was seen to
possess a similar loss of inhibitory function as that of the LSL
mutant (Fig. 8, A and B). Reducing the interactions to both Gi
and G subunits by including both point mutations (“LSL/RF”)
was found to be equivalently deleterious to the inhibitory func-
tion of GPSM3. Thus, both the GiGDP/GoLoco motif and
G/GPSM3 interactions are required for the inhibitory effect of
GPSM3 on this particular GPCR/effector signal transduction
system.
A second and well characterized G effector is the class IB
phosphatidylinositol 3-kinase (PI3K). Once activated, PI3K
leads to the generation of plasma membrane-delimited,
3-phosphorylated phosphatidylinositols and subsequent acti-
vation of the downstream effector protein kinase B (PKB or
Akt). Phosphorylation of endogenous Akt is an established
PI3K-specific read-out system (48). As the p101 regulatory sub-
unit of PI3K is known to bind directly to G and has a
restricted expression to the hematopoietic cell lineage, we also
investigated the activation of this pathway in the THP-1 cell
line that expresses endogenous levels of GPSM3.We produced
two independent THP-1-derived cell lines, each expressing a
different shRNA targeting the GPSM3 transcript, as follows:
one targeting the coding sequence (sh19) and the other one
targeting the 5UTR region (sh20). A control THP-1 cell line
was generated by infectionwith lentivirus obtained from empty
vector (pLKO.1). Both sh19 and sh20 THP-1 cell lines have a
60% or greater decrease in endogenous GPSM3 expression lev-
els as compared with the control pLKO.1 THP-1 cell line (Fig.
8C). Upon serum-starving these cell lines for 2 h and then stim-
ulating with FBS-containing medium for 30 min, the control
THP-1 cells exhibited an 3-fold increase in Akt phosphory-
lation (Ser-473; Fig. 8D); however, both GPSM3-knockdown
THP-1 cell lines showed no observable increase in Akt phos-
phorylation. This evidence of endogenous GPSM3 acting in a
pathway involving G- and phosphatidylinositol-mediated
signaling to Akt activation (Fig. 8D), coupled with the ability of
ectopic GPSM3 expression to suppress G-mediated inositol
phosphate production (Fig. 8, A and B), suggests a role for
GPSM3 in scaffolding and/or coordinating G subunit-depen-
dent cellular signaling.
Conclusions—A role for GPSM3 as a novel regulator of het-
erotrimer-GPCR complex formation and function is suggested
by evidence of GPSM3-mediated stabilization of neosynthe-
sized G, its well described role as a GiGDP-interacting pro-
tein, and recent BRET data (coupled with our BiFC, BRET, and
FRET results) (21) establishing a proximal complex between
GPSM3, G-protein subunits, and the 2-adrenergic receptor.
The plasma membrane-spanning nature of GPCRs, and conse-
quent requirement for lipid modification of heterotrimeric
G-protein subunits for efficient assembly with GPCRs, adds
complexity to the subcellular routing by which G-proteins,
receptors, and effectors assemble together after their initial
FIGURE 8. GPSM3 influences G-mediated signaling to inositol phos-
phate accumulation and phosphatidylinositol-dependent Akt activa-
tion. A, inositol phosphate accumulation upon agonist-induced activation of
the lysophosphatidic acid receptor LPA1R was measured in HEK293 cells co-
transfected with LPA1R expression vector and the indicated cDNAs. GPSM3
LSL and RF mutants lack the capacity to interact with G and Gi subunits,
respectively, as established in Figs. 6 and 7; wild-type GPSM3 is denoted wt.
B, effect of GPSM3 expression on direct activation of PLC2 by free G12
dimers was measured by inositol phosphate accumulation assays in COS-7
cells transiently co-transfected with indicated expression plasmids. All values
are the means  S.E. of three separate experiments; *, p  0.05 and ***, p 
0.001 by one-way ANOVA. C and D, activation of Akt, a downstream effect of
G-activated PI3K function, was analyzed in THP-1 cell lines stably infected
with a control vector pLKO.1 or with two different shRNA vectors (sh19 and
sh20) targeting GPSM3 for RNA interference knockdown. C, whole cell lysate
from the three derived cell lines were blotted against endogenous GPSM3,
showing reduced expression in the sh19 and sh20 infected THP-1 cell lines.
D, phosphorylation of Akt on serine 473 following 30 min of treatment with
10% FBS-containing medium was assayed by immunoblotting. Akt activation
was only detected in the control pLKO.1 THP-1 cell line and absent in the two
cells line with reduced GPSM3 expression.
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synthesis (49, 50). The timing and subcellular localization of
assembly events may influence the composition of the mature
signaling complex and hence determine its specificity. How the
G subunit is recruited to the nascent G dimer to initially
create the heterotrimer is still not clear (49), nor are the cellular
mechanisms by which specificity is achieved among the multi-
ple couplings possible between G, G, and G subunits. In
this context, GPSM3 may represent a G-protein subunit co-
chaperone or scaffold that fosters integration of different ele-
ments, including receptor and G-protein  and  subunits, to
form a functional signaling unit, as well as squelches inappro-
priate signaling by acting on G (through its GoLoco motif
guanine nucleotide dissociation inhibitor activity) until it forms
the mature heterotrimer with newly assembled G.
The presence of GPSM3 at the plasma membrane, high-
lighted in this study as well as a previous report showing regu-
lation of the GPSM3-Gi complex formation by agonist-stim-
ulated GPCRs (21), suggests that GPSM3 is not acting solely on
G during synthesis but also on G-protein subunits during
GPCR activation. It is presently unclear, however, how these
Gi and G interactions with GPSM3 functionally articulate
with regulation of heterotrimeric G-protein dynamics and
GPCR signaling. Intracellular GPSM3 could also participate in
noncanonical signaling by G-proteins other than at the plasma
membrane (39).
Our present discovery of a G/GPSM3 interaction should
help further elucidate the physiological role of GPSM3 in
G-protein signal transduction and may foreshadow GPSM3 as
an interesting target for the selective modulation of G-protein
signaling in the immune system.3
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